Case study: treatment-resistant schizophrenia - The Pharmaceutical Journal
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
Vicks Drug of Choice List | PDF | Enzyme Inhibitor | Nonsteroidal Anti Inflammatory Drug
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
PDF) Strategies in clozapine-resistant schizophrenia: A literature review
UNIVERSIDADE DE LISBOA FACULDADE DE FARMÁCIA STUDY OF THE UNDERLYING BASIS FOR VALPROATE HEPATOTOXICITY: DRUG METABOLISM AND
Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders | Chemical Reviews
Delaying clozapine: how long is too long? | General Psychiatry
PDF) Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study
Frontiers | N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials | SpringerLink
RETRACTED ARTICLE: Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials | SpringerLink
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
PDF) N -Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy | SpringerLink
Annual Report 2008 - Istituto di Ricerche Farmacologiche Mario Negri
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
